Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

The Immune Synapse as a Novel Target for Therapy

-15% su kodu: ENG15
143,97 
Įprasta kaina: 169,38 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
143,97 
Įprasta kaina: 169,38 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 169.3800 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 20,00 

Knygos aprašymas

It is now accepted that T cell activation by an antigen-presenting cell requires the organization of a supramolecular structure ¿ the immune synapse. This structure, with different types of molecules spatially segregated, is involved in the delivery of quantitative and qualitative signals critical for T cell activation, and therefore in controlling the nature of the immune response. This volume discusses the progress in manipulating components of the immune synapse as a strategy to regulate the immune response in immune pathology, such as transplantation, autoimmunity and allergy. Donnadieu reviews the current knowledge on the molecular composition and organization of the immune synapse and how the formation of this structure can be modulated by chemokines. It is also known that the immune synapse formation is critical for the activation of naive T cells, as well as their functional polarization. The second chapter discusses the conversion of naive T cells into regulatory T cells (Treg) when components of the immune synapse are manipulated in such a way that the T cells receive suboptimal activation signals.

Informacija

Serija: Progress in Inflammation Research
Leidėjas: Birkhäuser Basel
Išleidimo metai: 2007
Knygos puslapių skaičius: 212
ISBN-10: 3764382953
ISBN-13: 9783764382957
Formatas: 250 x 175 x 18 mm. Knyga kietu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „The Immune Synapse as a Novel Target for Therapy“

Būtina įvertinti prekę

Goodreads reviews for „The Immune Synapse as a Novel Target for Therapy“